Banque Pictet & Cie’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,350
| Closed | -$258K | – | 446 |
|
|
2025
Q4 | $258K | Hold |
10,350
| – | – | ﹤0.01% | 384 |
|
|
2025
Q3 | $264K | Hold |
10,350
| – | – | ﹤0.01% | 376 |
|
|
2025
Q2 | $251K | Hold |
10,350
| – | – | ﹤0.01% | 346 |
|
|
2025
Q1 | $262K | Sell |
10,350
-4,758
| -31% | -$125K | ﹤0.01% | 367 |
|
|
2024
Q4 | $401K | Buy |
15,108
+1,318
| +10% | +$35.8K | ﹤0.01% | 298 |
|
|
2024
Q3 | $399K | Buy |
13,790
+3,354
| +32% | +$97.8K | ﹤0.01% | 275 |
|
|
2024
Q2 | $292K | Buy |
10,436
+86
| +0.8% | +$2.37K | ﹤0.01% | 281 |
|
|
2024
Q1 | $287K | Hold |
10,350
| – | – | ﹤0.01% | 297 |
|
|
2023
Q4 | $298K | Sell |
10,350
-368,703
| -97% | -$11.1M | ﹤0.01% | 310 |
|
|
2023
Q3 | $12.6M | Buy |
379,053
+74,281
| +24% | +$2.63M | 0.15% | 72 |
|
|
2023
Q2 | $11.2M | Buy |
304,772
+75,789
| +33% | +$2.95M | 0.1% | 102 |
|
|
2023
Q1 | $9.34M | Sell |
228,983
-17,349
| -7% | -$749K | 0.09% | 109 |
|
|
2022
Q4 | $12.6M | Sell |
246,332
-37,967
| -13% | -$1.82M | 0.13% | 86 |
|
|
2022
Q3 | $12.4M | Buy |
284,299
+106,763
| +60% | +$5.19M | 0.14% | 87 |
|
|
2022
Q2 | $9.31K | Sell |
177,536
-75,486
| -30% | -$3.85M | 0.09% | 102 |
|
|
2022
Q1 | $13.1M | Buy |
253,022
+13,970
| +6% | +$725K | 0.1% | 94 |
|
|
2021
Q4 | $14.1M | Buy |
239,052
+3,420
| +1% | +$169K | 0.1% | 100 |
|
|
2021
Q3 | $10.1M | Buy |
235,632
+32,505
| +16% | +$1.44M | 0.11% | 91 |
|
|
2021
Q2 | $7.95M | Sell |
203,127
-3,893
| -2% | -$151K | 0.09% | 108 |
|
|
2021
Q1 | $7.5M | Sell |
207,020
-21,473
| -9% | -$762K | 0.1% | 110 |
|
|
2020
Q4 | $8.41M | Sell |
228,493
-37,655
| -14% | -$1.38M | 0.11% | 94 |
|
|
2020
Q3 | $9.27M | Sell |
266,148
-29,975
| -10% | -$1.05M | 0.14% | 84 |
|
|
2020
Q2 | $9.19M | Buy |
296,123
+28,245
| +11% | +$960K | 0.15% | 77 |
|
|
2020
Q1 | $8.3M | Sell |
267,878
-36,415
| -12% | -$1.24M | 0.17% | 73 |
|
|
2019
Q4 | $11.3M | Sell |
304,293
-22,355
| -7% | -$796K | 0.2% | 74 |
|
|
2019
Q3 | $11.1M | Buy |
326,648
+122,852
| +60% | +$4.47M | 0.21% | 68 |
|
|
2019
Q2 | $8.38M | Buy |
203,796
+40,276
| +25% | +$1.6M | 0.15% | 85 |
|
|
2019
Q1 | $6.59M | Sell |
163,520
-7,275
| -4% | -$291K | 0.13% | 111 |
|
|
2018
Q4 | $7.07M | Sell |
170,795
-19,131
| -10% | -$794K | 0.14% | 100 |
|
|
2018
Q3 | $7.94M | Buy |
189,926
+27
| +0% | +$1.04K | 0.15% | 104 |
|
|
2018
Q2 | $6.54M | Buy |
189,899
+7,367
| +4% | +$252K | 0.13% | 128 |
|
|
2018
Q1 | $6.15M | Buy |
182,532
+60,394
| +49% | +$2.08M | 0.13% | 128 |
|
|
2017
Q4 | $4.2M | Buy |
122,138
+21,899
| +22% | +$747K | 0.08% | 151 |
|
|
2017
Q3 | $3.4M | Buy |
100,239
+3,268
| +3% | +$105K | 0.08% | 165 |
|
|
2017
Q2 | $3.09M | Sell |
96,971
-31,770
| -25% | -$1M | 0.07% | 167 |
|
|
2017
Q1 | $4.18M | Buy |
128,741
+61,725
| +92% | +$1.95M | 0.1% | 139 |
|
|
2016
Q4 | $2.06M | Sell |
67,016
-25,328
| -27% | -$773K | 0.05% | 182 |
|
|
2016
Q3 | $2.97M | Sell |
92,344
-7,212
| -7% | -$241K | 0.08% | 146 |
|
|
2016
Q2 | $3.33M | Sell |
99,556
-17,688
| -15% | -$565K | 0.09% | 139 |
|
|
2016
Q1 | $3.3M | Buy |
117,244
+17,119
| +17% | +$489K | 0.09% | 137 |
|
|
2015
Q4 | $3.07M | Sell |
100,125
-35,758
| -26% | -$1.12M | 0.08% | 137 |
|
|
2015
Q3 | $4.05M | Buy |
+135,883
| New | +$4.36M | 0.12% | 124 |
|
|
2015
Q2 | – | Sell |
-179,102
| Closed | -$5.91M | – | 443 |
|
|
2015
Q1 | $5.91M | Buy |
179,102
+18,874
| +12% | +$600K | 0.15% | 125 |
|
|
2014
Q4 | $4.74M | Buy |
160,228
+24,652
| +18% | +$707K | 0.12% | 136 |
|
|
2014
Q3 | $3.8M | Sell |
135,576
-4,911
| -3% | -$138K | 0.1% | 147 |
|
|
2014
Q2 | $3.96M | Sell |
140,487
-2,315
| -2% | -$66K | 0.1% | 145 |
|
|
2014
Q1 | $4.35M | Sell |
142,802
-131,778
| -48% | -$3.93M | 0.12% | 129 |
|
|
2013
Q4 | $7.98M | Buy |
+274,580
| New | +$7.99M | 0.24% | 76 |
|
Other funds holding PFE
VCM
VPM
Banque Pictet & Cie's PFE Position: Q1 2026 in Review
Banque Pictet & Cie sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,350 shares — an estimated $258K sold.
Banque Pictet & Cie first reported a position in PFE in Q4 2013 and held it in 48 quarters. The position peaked at $14.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Banque Pictet & Cie reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Banque Pictet & Cie sold 10,350 Pfizer shares in Q1 2026, an estimated $258K.
- Banque Pictet & Cie first reported a position in Pfizer in Q4 2013 and held it in 48 quarters.
- Banque Pictet & Cie's Pfizer position peaked at $14.1M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.